AlphaYouKM
Insider selling
Kevin Mcculloch sold $127K of Xeris Biopharma Holdings, Inc. (XERS) stock
Kevin Mcculloch sold 15,000 shares of XERS stock worth $127K, per an SEC Form 4 filed Sep 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Sep 1, 2026.
XERS has moved +4.4% since the trade date, from $8.43 to $8.80 (Sep 21, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 1, 2026
- Filing delay
- 0 days
- Price since
- +4.4%
- Source
- SEC Form 4
More XERS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.